AgMedica Bioscience Inc. granted EU GMP (European Union Good Manufacturing Practices) certification

(Chatham, ON) – Thursday, July 21st, 2022 AgMedica Bioscience Inc. has been granted EU GMP certification (European Union Good Manufacturing Practices) from Bezirksregierung Detmold (Cologne District Government, Germany) for dried flower produced in its pharma-grade indoor grow facility located in Chatham, Ontario.

EU GMP certification is the highest recognition available to companies in the pharmaceutical space. AgMedica has demonstrated capability in following the guidelines that provide instruction for manufacturing, testing, and quality assurance in order to ensure AgMedica’s product is safe for human consumption. This certification is an essential piece needed to export EU GMP certificated pharmaceutical grade medical cannabis to importers and distributors in international markets that require EU GMP certification, allowing for global expansion.

Dr. Trevor Henry, CEO, AgMedica Bioscience Inc. commented: “This achievement is another assent to AgMedica’s approach to quality, consistency, and high standards. Achieving EU GMP gives AgMedica access to markets throughout Europe and across the globe.”

“Every step of our process, from cultivation to packaging, is diligently recorded and tracked. These measures are just some of the requirements for EU GMP certification, ensuring our facility meets with the most rigorous manufacturing standards. ” Lori Lynn Verbeem, Quailty Assurance Manager, AgMedica Bioscience Inc.

AgMedica has allied with its strategic partner enua Pharma (enua.de), a German based pharmaceutical company that has been crucial in helping bridge the gap between the Canadian and German markets. enua Pharma is a leading licensed distributor and manufacturer for medical cannabis in Germany, offering premium pharmaceutical-grade cannabis under its own brand. Together with AgMedica´s help, enua Pharma will be able to meet the exponentially growing demand of high quality cannabis products in Germany.

Lars Möhring, CEO, enua Pharma GmbH commented: “We are pleased to finally obtain the EU GMP certification of our exclusive strategic partner, AgMedica. This partnership will help us to strengthen our position as the largest cannabis distributor in Germany. Under our own enua brand, we will commercialize cannabis with high potency and rich of terpenes, to meet the patients needs which are unmet as of today.“

AgMedica distinguishes itself as one of few fully indoor grow facilities in Canada that have achieved this level of certification. This certification joins the growing list of granted certifications, which include:
– Health Canada certifications to cultivate, process and sell cannabis
– Israel Medical Cannabis Standard (IMC-G.A.P) [CUMCS equivalency] by the Israeli Medical Cannabis Agency (IMCA)

ABOUT AGMEDICA BIOSCIENCE INC.
AgMedica Bioscience Inc. is a Canadian-based licensed producer serving the global cannabis market. We are dedicated to product quality and consistency, patient care and customer satisfaction. We are committed to building a trusted and innovative cannabis business that will continue to set the benchmark for excellence for years to come.

AgMedica is located in Chatham, Ontario, our heritage in agriculture and horticulture, combined with our pharma-grade growing standards, ensure that we deliver products that consistently delight our patients and recreational consumers.

Similar Posts: